The conserved phenotypic role of IGF2BP1 in tumor-derived cells suggests that the protein, in addition to promoting MYC synthesis, enhances additional oncogenic pathways not or barely affected by the other IGF2BP homologs. The gene discussed is IGF2BP1; the disease is neoplasm.